Neutralizing antibodies are the interceptors of our immune system. They bind precisely to pathogens and prevent them from entering our cells. After an infection, the immune system needs about two weeks to produce mature...
The Pharmacokinetics/Pharmacodynamics unit (PK/PD unit) at the Helmholtz Centre for Infection Research (HZI) in Braunschweig investigates the potential of drug candidates against pathogens, using special testing...
Currently, little is known about children and their susceptibility to the new coronavirus. It has been observed that young children have rarely presented with COVID-19 up to now. No specific investigations have been...
Innovations based on proven active ingredients, new indications for established drugs – the principle of repurposing has often led to success in medicine. This is why it is also used against SARS-CoV-2: In order to...
Several whip-like appendages, called the flagella, protrude from the body of bacteria such as Salmonella Typhimurium. It has long been understood that the flagella are responsible for bacterial motility, which enables...
Außergewöhnliche Situationen bringen die Menschen näher zusammen. Das gilt aktuell in unserer Region. Während sich das Klinikum Braunschweig auf große Herausforderungen einstellt, ist die Hilfsbereitschaft von...
Scientists at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) have developed a strategy to administer antibacterial agents in a way that makes them many times more effective. Their results give rise...
The GSI Helmholtzzentrum für Schwerionenforschung and the FAIR GmbH (GSI/FAIR) uses its research potential and unique infrastructure to contribute to the management of the current corona pandemic. In several areas at...
